Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Green barley mitigates cytotoxicity in human lymphocytes undergoing aggressive oxidative stress, via activation of both the Lyn/PI3K/Akt and MAPK/ERK pathways


Oxidative stress plays a critical role in numerous diseases. Therefore, the pursuit of compounds with antioxidant activity remains critical. Green barley young leaves aqueous extract (GB) was tested for its capacity to ameliorate cellular oxidative stress, and its potential cytoprotective mechanism was partially elucidated. Through Folin-Ciocalteau and 1,1-diphenyl-2-picrylhydrazyl (DPPH) colorimetric assays, GB total phenolic content and free radical scavenging activity were found to be 59.91 ± 2.17 mg/L and 110.75 µg/ml (IC50), respectively. Using a live cell-based propidium iodide dye exclusion assay and flow cytometry, GB was found to display significant cytoprotection activity on three human lymphocytic cell lines exposed to an aggressive H2O2-induced oxidative stress. The molecular mechanism for GB cytoprotection activity was assessed via bead-based xMAP technology on the Luminex platform and western blot analysis. GB treatment resulted in activation of Lyn, Akt, and ERK1/2, suggesting that GB is able to mitigate the H2O2-induced oxidative stress via activation of both the Lyn/PI3K/Akt and ERK/MAPK pathways. Our findings support the notion that GB extract has the potential to be a valuable therapeutic agent and may serve to establish a strategy to discover potential compound(s) or biological extracts/mixtures to be incorporated as a treatment to prevent oxidative stress-related diseases.


Oxidative stress plays a pivotal role in the initiation and progression of a plethora of diseases, including aging-associated illnesses, chronic inflammation, cardiovascular disease, diabetes, and oncogenesis. An adequate balance of free radicals is necessary for maintaining cellular homeostasis, and this is possible due to the intervention of antioxidants with free radical scavenger activity. The Plantae kingdom provides us with major amounts of antioxidants as part of our diet1. Therefore, focusing on the potential protective benefit of an extensive variety of chemical compounds with antioxidant effects, particularly those derived from fruits, vegetables, and edible plants is an ongoing important task2. Discovering plant-derived extracts with antioxidant activity remains a prominent endeavor in medicinal chemistry.

Young barley leaves extract, also referred to as green barley (GB), is widely consumed as a dietary supplement3. In addition to its vitamin and mineral content, studies have suggested that GB exhibits antioxidant properties and could help alleviate inflammatory diseases4,5. In the mid-1990s, a commercial GB (“Natural SOD”) available for human intake was fractionated, and three of those fractions were able to reduce the tumor necrosis factor-alpha (TNF-α) production/release in human monocytes THP-1 cell line6. A similar effect was observed in mononuclear cells isolated from peripheral blood and synovial fluid from patients afflicted with rheumatoid arthritis (RA)4. Around the same time, it was reported that a single compound isolated from green barley leaves exhibited antioxidant properties5. It was later clarified that the major flavonoid antioxidants in young green barley leaves were, in fact, the flavone-C-glycosides, saponarin, and lutonarin7,8,9. Further studies showed that the antioxidant activity obtained from a combination of saponarin/lutonarin (4.5:1 proportion) was comparable to that obtained from vitamin E (α-tocopherol) and butylated hydroxytoluene, two well known antioxidant compounds10. More recently, it was reported that gramine (also called donaxine), a natural indole alkaloid found in young barley Hordeum vulgare L. and other plant species, attenuates inflammation and cell proliferation in oral carcinogenesis involving the NF-κB and STAT3 pathway11. In addition, whole barley kernel extracts have been shown to exhibit antioxidant, antiradical, and antiproliferative capabilities on the colorectal cancer cell line Caco-212. Other reports suggest that green biomass from young barley plants retains significant amounts of antioxidant enzymes like superoxide dismutase and catalase, as well as the non-enzymatic antioxidants vitamins C and E13,14. In agreement with these reports, a clinical study comprising 36 type 2 diabetic patients ingesting daily supplements of barley leaves in combination with antioxidant vitamins (C and E) conveniently decreased the low-density lipoprotein (LDL)-vitamin E content and blocked small dense-LDL oxidation, consequently decreasing some of the major risk factors of atherosclerosis and protecting type 2 diabetic patients against vascular diseases15. Lastly, GB has been shown to exert both antiproliferative and pro-apoptotic activities on human leukemia/lymphoma cells3.

In this study, we explored the potential prophylactic effect of GB on cells undergoing aggressive H2O2-induced oxidative stress. We also investigated the cell signaling implicated in the GB-cytoprotection activity. Overall, our data indicate that GB possesses potent free radical scavenger properties and attenuates H2O2-induced cell death. Our findings support the notion that the GB extract has the potential to be a valuable therapeutic agent in precluding oxidative stress-induced conditions.

Materials and Methods

Green barley extracts (GB) preparation

Aqueous green barley extracts (GB) were prepared as previously described3,16 by using dry powder from young leaves of Hordeum vulgare L., an herbaceous supplement sold as a proactive source of antioxidants, vitamins, and minerals (Vitamin World; Briefly, rehydrated green barley powder suspensions in phosphate buffer saline solution (PBS) or double distilled water (ddH20) were frozen (−80 °C) and thawed (room temperature) three times. The samples were then sonicated, centrifuged and filtered (0.2 µm pore size) for sterilization purposes. Typical volumes in microliters and their corresponding lyophilized dry weight values in mg/ml were measured as previously described3: 10 µl, 25 µl and 50 µl of GB are equivalent to 0.3 ± 0.009, 0.75 ± 0.006 and 1.5 ± 0.048 mg/ml of lyophilized powder, respectively.

Quantification of GB total phenolic content using Folin-Ciocalteu reagent

The amount of GB total phenolic content was determined by using the Folin-Ciocalteau colorimetric assay, which utilizes gallic acid as a standard reagent (modified from Ainsworth et al.)17. GB samples were prepared by mixing 17.1 µl of GB aqueous solution (30.85 ± 0.009 mg/ml of GB dry weight) with 82.9 µl of water, added with 0.2 ml of 10% v/v of Folin-Ciocalteau reagent (Sigma-Aldrich, St. Louis, MO), sonicated for 10 seconds and allowed to stand for 30 min in the dark at room temperature. Subsequently, 0.8 ml of 700 mM sodium bicarbonate aqueous solution was added to the reaction, sonicated for an additional 10 seconds and incubated 2 h as described above. An aliquot of 250 µl of each reaction mixture was transferred to a 96-well plate and the absorbance of each sample at 735 nm was determined by using a microplate-reader spectrophotometer (Tecan; Morrisville NC). The GB final concentration of 478.20 µg/ml of dry weight was reached to match the highest concentration used in the DPPH assay. For the reference reagent, a stock solution of 5 g/L gallic acid in methanol was utilized to prepare eight working standards, containing equivalent phenol concentrations of 25, 50, 75, 100, 125, 150, 175, and 200 mg/L gallic acid; an effective range to generate the calibration curves. An aliquot of 0.1 ml of each working standard was mixed with 0.2 ml of Folin-Ciocalteau reagent and then added with 0.8 ml of 700 mM sodium bicarbonate; sonication and incubation conditions were performed as above. A sample containing just water and reagents was used as a reference blank. The total phenolic content was expressed as milligrams of gallic acid equivalent (mg/L GAE). Both experimental and standard samples were performed in quadruplicates for each experiment. The gallic acid standard curve was created by plotting the average absorbance (A735) values for each data point (y-axis) versus mg/L of gallic acid equivalent (GAE; x-axis). The best-fit regression line was added to calculate the intercept and slope for the gallic acid standards. The equation utilized to obtain the total phenolic content in GB is depicted in Fig. 1b.

Figure 1

GB total polyphenol content of GB is 59.91 ± 2.17 mg/L gallic acid equivalents (GAE). (a) Correlation between total polyphenolic content and the absorbance (A735nm). The orange square corresponds to GB, 59.91 ± 2.17 mg/L GAE value, whereas purple squares to gallic acid working standards used as reference reagent. Linearity of calibration curve with correlation coefficient (R-squared, R2 = 0.9919) and linear equation are included in the graph (y = 0.0058 × −0.039). (b) The equation used to calculate the GAE value. Each data point represents the mean of four replicas. For each data point, the standard deviations of absorbance (A735 nm) were consistent with <0.072 (data not shown).

GB antioxidant analysis using cell-free DPPH radical assay

To evaluate free radical scavenging activity of GB, the 2,2-diphenyl-1-picrylhydrazyl (DPPH; Sigma, St Louis, MO) free radical colorimetric assay was utilized by recording its absorbance spectrophotometrically18. To find the GB optimal concentration for this assay, an aqueous solution containing 30.85 ± 0.009 mg/ml of GB dry weight was tested at 1:2 serial dilutions mode (in methanol; Sigma); finding an optimal range from 485.8 µg/ml to 15.1 µg/ml. Solutions of DPPH free radical were prepared in methanol at a concentration of 1 mM (20X), followed by further dilution, also in methanol, to 50 µM (1X working solution). As antioxidants controls, solutions of reduced glutathione (L-Glutathione(GSH); Sigma) and vitamin E (α-tocopherol) and their 1:2 serial dilutions, prepared in methanol, were included in a range from 50 µM to 1.56 µM final concentration per reaction. Moreover, water and methanol samples were used as solvent control and blank, respectively. Aliquots of 200 µl per well containing GB extract in a 96-well solid-bottom plate, were added with 100 µl of 50 µM DPPH (1X) and incubated at room temperature for 1, 10, 20 and 30 minutes in the dark; DPPH final concentration per reaction (300 µl total volume) was of 16.66 µM. GSH and vitamin E were concomitantly processed in a similar manner. The DPPH absorbance at 517 nm was measured by using a microplate absorbance reader for 96-well plates (Tecan Systems, San Jose, California).

The percentage of antioxidant activity (AA%), equivalent to the percentage of DPPH purple color reduction, was determined by comparison with the absorbance of methanol-containing controls (blanks) and converted into the percentage of antioxidant activity by using the following equation:

$${\rm{AA}} \% =100-[\frac{AU\,{\rm{methanol}}-AU\,{\rm{of}}\,{\rm{extract}}}{AU\,{\rm{methanol}}}]\times 100$$

AU corresponds to Absorbance Units recorded at 517 nm. The rate (%) of DPPH∙ discoloration specifies the free radical scavenging efficiency of the experimental extract or chemical compound19. Values are reported as the average ± standard deviation (SD) of five independent experiments. The inhibitory concentration 50% (IC50) value for GB as a free radical scavenger was calculated by linear interpolation of the best-fit regression line. Here, IC50 is defined as the antioxidant concentration required to reduce 50% of the DPPH present in the reaction after 30 min of incubation.

Cell lines and culture conditions

Three human lymphocytic cell lines were utilized; YT natural killer (NK)-like lymphoma20,21,22, pre-B acute lymphoblastic leukemia Nalm-623 and mature T acute lymphoblastic leukemia Jurkat24; all cell lines were derived from a male donor25 (Table 1). The culture medium was routinely RPMI (HyClone, Logan UT, USA) supplemented with 10% heat-inactivated fetal bovine serum (HyClone) and 100 U/ml penicillin and 100 μg/ml streptomycin (Lonza, Walkersville, MD); also referred as complete medium. Cells were routinely incubated at 37 °C in humidified 5% carbon dioxide (CO2) atmosphere using a regular water-jacketed incubator. To secure high viability, before preparing an experimental multi-well plate, cells were processed as detailed previously26.

Table 1 Leukemia/lymphoma cell lines utilized in this study.

H2O2-induced oxidative stress assay

Exponentially growing cells at 60–75% confluence were collected and seeded on 24-well plates at a density of 100,000 cells/well in 1 ml of complete media. After overnight incubation, cells were treated with 10 or 50 µl of GB and incubated another 18 h. Next, cells were collected and centrifuged (262 × g for 5 min) to remove supernatant, washed with pre-warmed (37 °C) complete media, resuspended with 1 ml of complete fresh media and plated in a 24-well plate. To induce oxidative stress, cells were exposed to 600 µM of H2O2 and incubated for an additional 24 h. Subsequently, cells were collected into an ice water pre-cooled flow cytometric tube, centrifuged and resuspended with a staining solution consisting of 400 μl of PBS containing 5 μg/ml of propidium iodide (PI), and incubated 1 min on ice protected from light. Control samples exposed to 600 µM H2O2 without GB pre-treatment were considered as the maximum toxicity possible and utilized as a reference to estimate the percentage of GB-protection effect. In addition, untreated cells and cells treated with 10 μl and 50 μl of PBS alone were included as controls. Both experimental samples, as well as controls, were handled identically and processed in parallel cultures. The cytotoxicity values are presented as mean ± standard deviation without any further normalization.

Cytotoxicity analysis using live-cell and propidium iodide exclusion assay

Vital dye propidium iodide (PI) exclusion assay was used to monitor cytotoxicity via flow cytometer. Cells stained with the membrane-impermeant dye PI (5 µg/ml), a nucleic acid intercalator, were examined in a live-cell manner by using flow cytometric protocol. Viable cells with intact plasma membranes exclude PI. The main objective was to identify the distribution of PI-positive cells, with loss of plasma membrane integrity, which was considered dead cell subpopulation. Cells were collected in a flow cytometric tube, stained with PI, gently vortexed and immediately analyzed using a flow cytometer (Cytomics FC500; Beckman Coulter, Miami, FL). For each sample, a maximum of 10,000 events (cells) was acquired and data analyzed using CXP software (Beckman Coulter, Miami, FL). The cytotoxicity percentages obtained are expressed as a mean ± standard deviation.

Luminex multiplex kinases analyses

Pre-B Nalm-6 cells growing as described above were seeded in a multi-well plate and treated with 25 and 50 µl/ml of GB for 3 h3. Subsequently, cells were washed with PBS and lysed with Milliplex MAP cell signaling lysis buffer containing a protease inhibitors cocktail (Millipore, Billerica, MA). The Milliplex MAP Human Src Family Kinase kit (Millipore, Billerica, MA) was used to detect tyrosine phosphorylation of Lyn (p-Tyrosine397), Yes (p-Tyrosine421) and Hck (p-Tyrosine411), by utilizing 25 µg of total protein per cell lysate following the manufacturer’s instructions (Millipore). Protein concentrations were determined using bicinchoninic acid (BCA) reagent (Thermo Scientific, Rockford, IL).

Analysis of Akt, MAPK/ERK and STAT5 phosphorylation via Western blot

The phosphorylation of Akt was assessed via Western blotting as detailed previously27. Nalm-6 cells seeded in a 6-well plate format were exposed to 50 µl/ml of GB for 3 h, pelleted, and lysed. The total protein content per cell lysate was quantified by the BCA method (Thermo Scientific). Equal concentration of protein per lane was separated by SDS-PAGE and transferred onto a polyvinylidene fluoride (PVDF) membrane (Millipore). Western blot assays were developed with horseradish peroxidase-conjugated goat anti-rabbit IgG (heavy plus light chains; KPL) and visualized using enhanced chemiluminescence and X-ray film or the C-DiGit Blot Scanner (LI-COR). When reblotting, polyvinylidene difluoride membranes were incubated with stripping buffer (100 mM β-mercaptoethanol, 2% SDS, 62.5 mM Tris-HCl, pH 6.7) at 55 °C for 30 min, blocked, and then reprobed. The anti-phospho-p44/42 MAPK (ERK1/2) Threonine (Thr) 202/Tyrosine (Tyr) 204 polyclonal antibody, anti-p44/42 MAPK (ERK1/2) polyclonal antibody, anti-phospho-AKT Threonine (Thr) 308 monoclonal antibody, anti-phospho-AKT Serine (Ser) 473 monoclonal antibody, anti-AKT monoclonal antibody, and anti-phospho-STAT5 Tyrosine (Tyr) 694 antibody were purchased from Cell Signaling Technology (Danvers, MA). The anti-STAT5 antibody was purchased from BD Biosciences (San Jose, CA). All antibodies were used according to the manufacturer’s protocol. Densitometry analysis of Western blots was performed using the ImageStudio software suite (LI-COR).

Statistical analysis

Each measurement was performed at least in triplicate. Data are displayed as average with its derived standard deviation to denote experimental variability. Two-tailed paired Student’s t-tests were performed to determine the statistical significance between the two sample groups. A value of P < 0.05 was deemed significant to indicate whether comparisons of two treatments possessed statistical significance.


Phenolic content in GB

The analysis of soluble phenolic compounds in GB was performed by using an aqueous solution prepared from green barley dry powder dissolved in ddH2O. Polyphenols in plant extracts or other samples, react specifically with redox Folin-Ciocalteu reagent forming a blue complex that can be measured by spectrophotometry. The polyphenolic contents in GB are expressed in gallic acid equivalents (GAE). The linearity of the calibration curve exhibited a correlation coefficient (R-squared, R2) of R2 = 0.9919 (Fig. 1a). The total polyphenolic content in GB was of 59.91 ± 2.17 mg/L GAE (average ± SD), assessed by using the equation depicted in Fig. 1b.

GB displays potent free radical scavenging activity

The conversion of DPPH∙ (2,2-diphenyl-1-picrylhydrazyl) free radical to DPPH (diphenyl-picryl hydrazine) reaction was utilized to evaluate the GB biological antioxidant capacity in vitro. GB exhibited a scavenging effect of 71.83% and 16.15% at the maximum (485.8 µg/ml) and minimum (15.1 µg/ml) concentration tested, respectively (Fig. 2a). The well-known antioxidants, glutathione (GSH) and vitamin E were tested from 50 to 1.56 µM concentrations, and as expected, both GSH and vitamin E revealed scavenging effect, being vitamin E most effective than GSH (Fig. 2b,c). The GB antioxidant pattern was comparable to vitamin E (Fig. 2a). In contrast, water and methanol failed to display antioxidant activity (Fig. 2a). Additionally, to explore whether the GB scavenging activity was a time-dependent occurrence, a GB serial dilution concentrations (1:2) were incubated with DPPH free radical as above for 1, 10, 20 and 30 min at room temperature and the absorbance was quantified (Fig. 2b). GSH and vitamin E were also analyzed. At 30 min of incubation, vitamin E was found to be ~3.5 fold times more efficient at 50, 25 and 12.5 µM concentration than GSH (Fig. 2c,d). The GB scavenging activity resembled that seen with vitamin E, instead of GSH (Fig. 2b–d). GB and vitamin E reached their substantial free radical scavenger activity after the first 10 min of incubation with minimum changes observed after (Fig. 2b,d). The IC50 value for GB scavenging activity was of 110.75 µg/ml (Fig. 2b), whereas vitamin E was of 7.552 µM (Fig. 2d). The IC50 value for GSH could not be determined since the DPPH scavenge was of 24.73% at the maximum concentrations tested (Fig. 2c). Thus, GB was capable of effectively scavenging the DPPH free radical reagent, in a concentration- and time-dependent manner, suggesting that GB is a potent free radical scavenger.

Figure 2

GB exhibits potent anti-oxidant activity evidenced by DPPH free radical scavenging assay in a dose and time-dependent manner. (a) A gradient of GB concentrations (485.8 µg/ml to 15.1 µg/ml) were incubated with DPPH for 30 min at room temperature, and the absorbance at 517 nm was recorded. DPPH radical scavenging activity was calculated according to the equation described in materials and methods. Glutathione (GSH) and vitamin E (50 to 1.56 µM) were included as positive antioxidant controls and analyzed concomitantly. Water was used as a solvent control, whereas methanol was used as a blank. Data are presented as the mean ± standard deviation of five independent experiments. Two-tailed paired Student’s t-tests were accomplished to determine the statistical significance of two experimental samples (P values). GB serial dilution concentrations (1:2; 485.8 to 15.1 µg/ml) were incubated with DPPH for 1, 10, 20 and 30 min at room temperature and the absorbance at 517 nm was recorded. Glutathione (GSH) (c) and vitamin E (50 to 1.56 µM) (d) were included as positive antioxidant controls and concurrently analyzed. Data are shown as the  average of five independent experiments.

GB exhibits protective activity in human lymphoid cells upon oxidative stress

A panel of leukemia/lymphoma cell lines was selected to review the cytoprotection effect of GB. The cytotoxicity percentages were measured by using vital dye PI exclusion assay monitored by flow cytometric protocol (Fig. 3). This approach identifies in vivo at a single-cell level PI-positive cells, embracing the cell population with plasma membrane damage, which is considered as dead cells28. Cells exposed to 10 µl/ml of GB (equivalent to 0.3 ± 0.009 mg/ml of GB dry weight) displayed moderate cytoprotection after exposure to H2O2 (Fig. 3a–c), however, based on the P value, a trend in this protective effect is observed. The three lymphoid cell lines pre-incubated with 50 µl/ml of GB (equivalent to 1.5 ± 0.048 mg/ml of GB dry weight) consistently exhibited a significant reduction in mortality after treatment with H2O2 (600 µM). YT, Nalm-6, and Jurkat cells showed a 13.29%, 15.5%, and 22.07% reduction in mortality respectively compared to the H2O2 control, with P values oscillating from 0.0017 to 0.0055 (Fig. 3a–c). No difference was observed on cells left untreated or treated with 10 µl/ml or 50 µl/ml of GB, indicating that the extract alone is not an influential factor in cell viability. The H2O2 insult (600 µM) resulted in less toxicity on Jurkat cells (46.2 ± 2.98%) whereas YT cells (62.97 ± 0.72%) were to some extent the most sensitive to this oxidative stress aggression (Fig. 3a–c). Representative flow cytometry dot plots are shown in Fig. 3d–g. An alternative strategy to quantify the cytotoxicity via vital dye PI exclusion assay using fluorescent microscopy is illustrated in Fig. 3h–j. Thus, GB exerted a consistently protective effect on the three human lymphoid cells undergoing oxidative stress on living cells.

Figure 3

GB ameliorated H2O2-induced oxidative stress in lymphocytic cells. Graphs exhibiting the protection effect of GB against H2O2 (600 µM) aggression are in panels (a–c) which correspond to YT, Nalm-6 and Jurkat, respectively; each bar represents an average of four independent experiments and the error bar its standard deviation. Cells seeded in a 24 well plate were incubated with GB for 18 h, washed, exposed to 600 µM of H2O2, incubated for an additional 24 h period, stained with PI and processed via flow cytometry. Untreated cells, as well as cells exposed to 10 and 50 µl of GB alone or exposed to just 600 µM of H2O2, were included as controls. Cell viability was determined by using PI exclusion dye and flow cytometric assay. Data acquisition and analysis of PI-positive cells (dead) distributions were performed via CXP software (Beckman Coulter). Statistical significance between two samples was calculated using Student’s t-test (P value). Panels d-g show representative two parameter flow cytometric dot plots, where FL1 and FL2 detectors were plotted at x-axis versus y-axis, respectively. PI-stained YT cells (dead) are depicted in top left quadrat, whereas PI negative unstained cells (living) in the bottom left quadrant; H2O2-treated cells (d); GB-pretreated (50 µl) cells followed by exposure to H2O2 (e); cells treated with 50 µl of GB alone (f); and untreated cells (g). The various dot (event/cells) color in each plot, designates a density gradient; low-density, blue dots, whereas high-density, red dots. An alternative strategy to quantify the cytotoxicity via vital dye PI exclusion assay using fluorescent microscopy in YT cells is illustrated in panels (h–j); bright field DIC image (h); cells exhibiting red fluorescence signal with compromised plasma membranes, PI positive (i); and a merged image of bright field and red channel (j). Scale bar = 20 µm.

GB enhances Lyn tyrosine kinase phosphorylation

A panel of Src tyrosine kinases involved in cell signaling was analyzed to elucidate whether those enzymes are implicated in the GB cytoprotection activity. Nalm-6 cells were exposed to GB and protein extracts were utilized to assess the activation of Lyn, Hck, and Yes. For this purpose, a bead-based multiplex technology and antibodies recognizing specific tyrosine phosphorylation sites, Lyn (Tyr397), Hck (Tyr411) and Yes (Tyr421) were utilized. Out of the three kinases, only Lyn was found to be activated by GB. Treatment of cells with 25 µl/ml and 50 µl/ml of GB resulted in a 40% (P = 0.026) and 70% (P = 0.002) increase in Lyn phosphorylation respectively compared to PBS-treated control (Fig. 4). In contrast, changes in phosphorylation levels of Hck (Tyr411) and Yes (Tyr421) kinases were not detected when compared with both PBS- and GB-treated cells (Fig. 4). Thus, GB stimulates the phosphorylation of Lyn (Tyr397) in pre-B Nalm-6 cells in a concentration-depended modality, suggesting its potential participation as an antioxidative stress kinase.

Figure 4

GB induced phosphorylation of Lyn tyrosine kinase in pre-B Nalm-6 cells. Protein extracts from pre-B Nalm-6 cells, treated with 25 and 50 µl/ml of GB for 3 h, were analyzed for activation of Src family kinases, Lyn, Yes and Hck, using the bead-based Luminex xMAP platform. Cells treated with 50 µl of PBS solvent control were concurrently analyzed. The median fluorescence intensity (MFI) is plotted in the y-axis; whereas the three Src family kinases are plotted in the x-axis. Each bar represents the average of three experiments and the error bars are their associated standard deviations. Statistical variability was determined using Student’s t-test. The 25 and 50 µl of GB correspond to 0.75 ± 0.024 and 1.5 ± 0.048 mg/ml of GB lyophilized powder, respectively. Data acquisition, processing, and analysis were achieved using xPONENT 3.1 software (Luminex).

GB induces activation of Akt and ERK1/2

The activation of Akt and p44/42 mitogen-activated kinase (MAPK), also known as extracellular signal-regulated kinase (ERK1/2) enzymes are necessary for transduction of the Lyn/PI3K/Akt and MAPK/ERK signaling pathways. Phosphorylation of these enzymes serves as robust markers involved in pro-survival cell signaling29,30. To investigate the potential involvement of Lyn/PI3K/Akt and MAPK/ERK pathways on GB protective effect, the phosphorylation levels of Akt and ERK1/2 were determined using phosphospecific antibodies to identify the active forms of both enzymes. Pre-B Nalm-6 cells were left untreated or exposed to GB for 1 and 3 h, and whole cell lysates were examined concomitantly via Western blot. As seen in Fig. 5, GB treatment resulted in a modest increment of Akt (Thr308) phosphorylation after 1 h. However, phosphorylation reached ~2 fold increase after a 3 h exposure (Fig. 5a). A similar phosphorylation pattern was detected for pAKT (Ser473), which is also indicative of AKT activation (Fig. 5a, lower panel). In addition, ERK1/2 phosphorylation increased ~2 fold after 1 h of GB treatment and reached ~3 fold increase at 3 h compared to the non-treated cells (Fig. 5b). Therefore, GB treatment resulted in activation of the Lyn/PI3K and MAPK/ERK pathways in a time-dependent manner which could contribute to diminishing cell death after oxidative stress.

Figure 5

GB elicited phosphorylation of both Akt and MAPK/ERK kinases in pre-B Nalm-6 cells in a time-dependent manner. Whole cell lysates were subjected to Western blot analysis with the antibodies indicated in material and methods. (a,b) The bar graphs represent densitometry analyses showing a comparable increase in pAkt (Ser 473) and pMAPK/ERK phosphorylation induced after 1 h and 3 h of GB-treated cells (50 µl), respectively (n = 2). As a reference control, lysates from untreated (Unt) pre-B Nalm-6 cells were included, and also, to establish the basal levels of Akt and MAPK/ERK phosphorylation; representative Western blots displaying GB-stimulated pAkt (Ser 473), pAkt (Thr 308) and pERK1/2 phosphorylation are shown in the lower panels. (c) The bar graph represents densitometry analysis showing a comparable increase in STAT5 (Tyr 694) phosphorylation caused after 1 h and 3 h of GB-treated cells (50 µl), respectively (n = 3). As a reference control, lysates from untreated (Unt) pre-B Nalm-6 cells were included; western blots are displaying GB-stimulated STAT5 phosphorylation, as compared with total STAT5 protein are shown in (c), lower panel. The 50 µl of GB correspond to 1.5 ± 0.048 mg/ml of GB lyophilized powder.

Another protein that plays a prominent role in proliferation and cell survival is the signal transducer and activator of transcription (STAT) 531. It’s been previously reported that the Janus kinase 2 (JAK2)/STAT5 pathway plays a crucial role in the survival and proliferation of chronic myeloid leukemia cells obtained from patients32. Thus, pre-B Nalm-6 cells were treated as described above and protein extracts investigated for activation of STAT5 via Western blot analysis. As seen in Fig. 5c, there was a slight increase (1.3 fold) in STAT5 phosphorylation compared to the non-treated control. Therefore, GB was able to modestly induce STAT5 phosphorylation, suggesting that the Lyn/PI3K and MAPK/ERK pathways play larger roles on GB effects than JAK2/STAT5.


Polyphenols are potent and the most abundant antioxidants in the diet, mainly supplied by fruits, vegetables and plant-derived beverages such as juices, tea, coffee, and red wine33. These compounds are effective in preventing inflammatory and cardiovascular diseases by neutralizing the damage caused by free radicals. The objective of this study was to explore whether an aqueous green barley extract (GB) contains polyphenols with the capacity to scavenge free radicals and exert its antioxidant protective activity on a panel of human lymphoid cells undergoing to H2O2-induced oxidative stress. The GB extract was found to have a total phenolic content of 59.91 ± 2.17 mg/L GAE, and its DPPH radical-scavenging activity was found to be 110.75 µg/ml (IC50). In addition, GB treatment resulted in activation of the pro-survival pathways Lyn/AKT and MAPK/ERK, and the reduction of H2O2-induced mortality. These findings suggest that GB could be an attractive source of antioxidants.

The antioxidant and anticancer activities in fruits and vegetables are attributable to the synergistic effect of their complex mixture of phytochemical components34. For instance, whole extracts of the “Red Delicious” apples (Malus pumila) had higher antioxidant activity and inhibited the proliferation of cancer cells more efficiently than apple extracts without skin35. Moreover, total polyphenol extracts from cranberries (Vaccinium macrocarpon Ait. Ericaceae) displayed more elevated anti-inflammatory and antiproliferative activity as compared with its individual components36. Studies have shown that extracts from mango (Mangifera indica L.), quince (Cydonia oblonga Miller) and banana (Musa paradisica) exerted protection on H2O2-induced oxidative toxicity in erythrocytes37,38,39. In addition, papaya (Carica papaya L.) epicarp extracts and date (Phoenix dactylifera) seed oil ameliorate the H2O2-induced oxidative stress insult in vitro in neuronal SH-SY5Y cells or normal human epidermal melanocytes, hypothesizing potential utility in patients with neurological disease or as a chemopreventive agent in melanocyte-related pathologies, respectively40,41. Plant antioxidants may decrease carcinogenesis by neutralization of ROS or other free radicals that can cause structural DNA damage, therefore decreasing the risk of tumor formation42. However, in the light of recent evidence, antioxidants should be considered cautiously in cancer afflicted patients, due that once that the cancer is established, an antioxidant therapy could favor cancer exacerbation43 and metastasis development44.

The total phenolic content of extracts or plants contributes to their antioxidant activity. The Folin–Ciocalteu assay, which is a standardized method used routinely to measure the polyphenolic content in foods, beverages, and dietary supplements was used to investigate GB. The extract was found to have 59.91 ± 2.17 mg/L GAE (Fig. 1). The scavenging activity of GB was assessed by a colorimetric assay of a methanol solution of cell-free DPPH free radical assay, which is a standard approach to evaluate antioxidants19. Here, GB was found to have a scavenging IC50 value of 110.75 µg/ml (Fig. 2), which is considered to be potent. Next, GB was examined for its capacity to protect cells undergoing H2O2-induced oxidative stress and death. Cells were pretreated with two concentrations of GB for 18 h. GB has been shown to express plasma membrane impermeable molecules like SOD and catalase, which have the capacity to degrade H2O26. Therefore, in order to remove their extracellular residual presence, a wash step with fresh warm (37 °C) media was included after the GB treatment. Subsequently, cells were exposed for an additional 24 h to a final concentration of 600 µM of H2O2 and their viability was examined via propidium iodide (PI) exclusion and flow cytometry. The criterion utilized to designate a dead cell was its loss of plasma membrane integrity, as previously reported45. Results indicate that low amount of GB extract (10 µl) showed moderate cytoprotection upon H2O2-induced oxidative stress. However, 50 µl of GB showed significant protection activity (P < 0.01) on YT, pre-B Nalm-6 and Jurkat cells (Fig. 3). These findings suggest that GB possess significant antioxidative protection in cells undergoing strong aggression inflicted by H2O2 in a concentration-dependent modality. Moreover, GB itself exhibited no cytotoxic activity at the concentrations used after 24 h of cell exposure. The results presented here are in agreement with the idea that plant products could be used as an option in antioxidative preventive medicine.

The activation of various signaling pathways was investigated to explain the mechanism used by GB in mitigating oxidative stress and reducing cell death. Initially, pre-B Nalm-6 cells were treated with GB and the phosphorylation of a panel of the Src family of tyrosine kinases (SFKs) was investigated. SFKs plays crucial roles in ample intracellular signal transduction. They mediate redundant as well as unique functions involving cell metabolism, activation, differentiation, proliferation, migration, and apoptosis among others46. The main SFKs member expressed in B cell lineages is Lyn, which has both positive and negative regulatory functions upon stimulation of a variety of signaling pathways47. In the intracellular space as a membrane-associated tyrosine kinase, Lyn is crucial for the regulation of B cell activation while the cytosolic Lyn cleaved soluble fragment can act as an inhibitor of apoptosis46,47,48. Lyn has been reported to be over-expressed in chronic lymphocytic leukemia (CLL) cells where it blocks apoptosis49. Here, our findings revealed that GB treatment of pre-B Nalm-6 cells results in the phosphorylation of Lyn (Tyr397) in a concentration-depended modality that is potentially implicated in the antioxidative mechanism that protects the lymphoid cells (Fig. 4). In line with this data, it has been demonstrated that Lyn and Fgr kinases possess anti-apoptotic activities in the human promyelocytic leukemia cell line (HL-60)50. Additionally, Lyn mediated tumor progression and cell motility in a head and neck squamous cell carcinoma model in vivo51. Moreover, in glioblastoma, Lyn contributed with a prominent increased activity facilitating cell survival52. These studies suggest that Lyn could be functioning as a protective anti-apoptotic kinase, making cancer cells more resistant to the anti-cancer immune response and/or to anti-cancer drugs.

Once activated, Lyn can phosphorylate signaling molecules leading to the activation of various signaling pathways, including PI3K53. In every tissue, numerous biological processes are regulated by the PI3K pathway. An important effector of PI3K signaling is Akt, also known as protein kinase B (PKB). Akt is a serine/threonine kinase that plays a crucial role in transducing PI3K cell survival signals54. Overexpression of a constitutively active Akt in lymphocytes in in vivo transgenic mice results in improvement of lymphocyte survival by preventing sepsis-induced apoptosis55. Consistent with these observations, thymocytes from fetal thymus organ primary culture of animals overexpressing Akt showed an increment in viability upon γ-radiation, dexamethasone, and Fas ligand exposure56. In addition, activation of Akt in Nalm-6 cells, has been shown to decrease the percentage of apoptotic cells induced by two clinically used anticancer drugs, vincristine and adriamycin57. Moreover, activation of the Lyn/PI3K/Akt pathway was found to be involved in the survival and proliferation of myeloma cells and resistance to apoptosis in juvenile myelomonocytic leukemia (JMML)58,59. In line with these studies, our findings revealed that GB treatment results in phosphorylation of Akt (both Thr308 and Ser473) in a pre-B Nalm-6 cell line in a time-dependent fashion (Fig. 5). The activation of this protein by GB treatment suggests that the Lyn/PI3K/Akt signaling pathway might be implicated in its cytoprotection mechanism.

Another well-recognized signaling pathway that can be activated by Lyn is MAPK/ERK, also involved in cell proliferation, differentiation, and survival49,60. MAPK/ERK activation leads to upregulation of cell cycle genes and blocking of apoptosis in CLL49. Also, both the MAPK/ERK and the PI3K/Akt pathways have been found to be essential for the survival of several breast cancer cell lines61. In this study, it was found that GB is able to induce phosphorylation/activation of ERK in a time-regulated mode (Fig. 5). Thus, in addition to the GB-mediated activation of Lyn/PI3K/Akt pathway, GB is also able to trigger the MAPK/ERK pathway and both contribute as cell pro-survival mechanisms, which potentially lead at least in part, to the GB cytoprotective effect. In addition to these pathways, several other biochemical pathways may participate in the mitigation of cytotoxicity in pre-B cells undergoing aggressive oxidative stress. In the future, it will be necessary to identify the survival-associated downstream targets affected by GB-mediated Lyn, MAPK/ERK, and Akt phosphorylation/activation.

Because of its role in promoting proliferation and survival of lymphoid cells, activation of the transcription factor STAT5 in response to GB was also assessed. STAT5 promotes the transcription of anti-apoptotic and cell cycle progression genes and was recently found to have a protective role against oxidative stress31,62. Inhibition of STAT5 expression in lymphoid pre-B cell lines, Nalm-6, 697 and Reh, lead to increased FAS-elicited cell death, and higher spontaneous apoptosis31. Here, treatment of Nalm-6 cells with GB resulted in a slight increase in STAT5 phosphorylation, indicating that GB confers its protective signals independently of the STAT5 cascade (Fig. 5). Therefore, under the circumstances tested, it appears that the contribution of the anti-apoptotic JAK2-STAT5 signaling pathway is unimportant as a protective mechanism elicited by GB; however, this pathway could have a potential additive or synergistic effect in preventing cell death concurrently with Lyn/PI3K/Akt and MAPK/ERK pathways. In addition to these pathways, several other biochemical pathways may participate in the mitigation of cytotoxicity in pre-B cells undergoing aggressive oxidative stress. In the future, it will be necessary to identify the survival-associated downstream targets affected by GB-mediated Lyn, MAPK/ERK, and Akt phosphorylation/activation.

Hence, based on the evidence presented here, GB contains phenolic compounds that exhibit potent free radical scavenging activities. Additionally, GB exerted a cytoprotective effect on human lymphoid cells, as evidenced by a significant reduction in cell death after oxidative stress exposure. Findings at the molecular level suggest that GB activated the pro-survival Lyn/PI3K/Akt and MAPK/ERK signaling pathways and these occurrences could be implicated in conveying its cytoprotective effect in human lymphoid cells. Our study describes a unique set of functional signaling transduction pathways and mechanisms of action of GB in lymphoid pre-B Nalm-6 cells, involved in mitigating cell death after oxidative stress. Therefore, it should be judicious to evaluate the GB-mediated properties in an animal model, as an herbal option comprising its antioxidant and cytoprotective activity.


  1. 1.

    Hanninen et al. Antioxidants in vegan diet and rheumatic disorders. Toxicology 155, 45–53 (2000).

    CAS  Article  Google Scholar 

  2. 2.

    Davies, K. J. Oxidative stress: the paradox of aerobic life. Biochem Soc Symp 61, 1–31 (1995).

    CAS  Article  Google Scholar 

  3. 3.

    Robles-Escajeda, E. et al. Searching in mother nature for anti-cancer activity: anti-proliferative and pro-apoptotic effect elicited by green barley on leukemia/lymphoma cells. PLoS One 8, e73508 (2013).

    ADS  CAS  Article  Google Scholar 

  4. 4.

    Cremer, L., Herold, A., Avram, D. & Szegli, G. A purified green barley extract with modulatory properties upon TNF alpha and ROS released by human specialised cells isolated from RA patients. Roum Arch Microbiol Immunol 57, 231–242 (1998).

    CAS  PubMed  Google Scholar 

  5. 5.

    Osawa, T., Katsuzaki, H., Hagiwara, Y., Hagiwara, H. & Shibamoto, T. A novel antioxidant isolated from young green barley leaves. Journal of Agricultural and Food Chemistry 40, 1135–1138 (1992).

    CAS  Article  Google Scholar 

  6. 6.

    Cremer, L., Herold, A., Avram, D. & Szegli, G. Inhibitory capacity of some fractions isolated from a green barley extract upon TNF alpha production by the cells of the THP-1 human monocytes line. Roum Arch Microbiol Immunol 55, 285–294 (1996).

    CAS  PubMed  Google Scholar 

  7. 7.

    Markham, K. R. & Mitchell, K. A. The mis-identification of the major antioxidant flavonoids in young barley (Hordeum vulgare) leaves. Z Naturforsch C 58, 53–56 (2003).

    CAS  Article  Google Scholar 

  8. 8.

    Seikel, M. K. & Geissman, T. A. The flavonoid constituents of barley (Horedum vulgare). I. Saponarin. Arch Biochem Biophys 71, 17–30 (1957).

    CAS  Article  Google Scholar 

  9. 9.

    Seikel, M. K., Bushnell, A. J. & Birzgalis, R. The flavonoid constituents of barley (Hordeum vulgare): III. Lutonarin and its 3′-methyl ether. Archives of Biochemistry and Biophysics 99, 451–457 (1962).

    CAS  Article  Google Scholar 

  10. 10.

    Benedet, J. A., Umeda, H. & Shibamoto, T. Antioxidant activity of flavonoids isolated from young green barley leaves toward biological lipid samples. J Agric Food Chem 55, 5499–5504 (2007).

    CAS  Article  Google Scholar 

  11. 11.

    Ramu, A. et al. Gramine attenuates EGFR-mediated inflammation and cell proliferation in oral carcinogenesis via regulation of NF-kappaB and STAT3 signaling. Biomed Pharmacother 98, 523–530 (2018).

    CAS  Article  Google Scholar 

  12. 12.

    Madhujith, T. & Shahidi, F. Antioxidative and antiproliferative properties of selected barley (Hordeum vulgarae L.) cultivars and their potential for inhibition of low-density lipoprotein (LDL) cholesterol oxidation. J Agric Food Chem 55, 5018–5024 (2007).

    CAS  Article  Google Scholar 

  13. 13.

    Ehrenbergerova, J. et al. Antioxidant enzymes in barley green biomass. Plant Foods Hum Nutr 64, 122–128 (2009).

    CAS  Article  Google Scholar 

  14. 14.

    Brezinova Belcredi, N., Ehrenbergerova, J., Fiedlerova, V., Belakova, S. & Vaculova, K. Antioxidant vitamins in barley green biomass. J Agric Food Chem 58, 11755–11761 (2010).

    CAS  Article  Google Scholar 

  15. 15.

    Yu, Y. M., Chang, W. C., Chang, C. T., Hsieh, C. L. & Tsai, C. E. Effects of young barley leaf extract and antioxidative vitamins on LDL oxidation and free radical scavenging activities in type 2 diabetes. Diabetes Metab 28, 107–114 (2002).

    PubMed  Google Scholar 

  16. 16.

    Varela-Ramirez, A., Robles-Escajeda, E., Lerma, D., Nyakeriga, A. M. & Aguilera, R. J. Green barley extract possesses selective antiproliferative and cytotoxic activity on human cancer cells. Molecular Biology of the Cell 23, 4663 (2012). Supplemental Material.

    Google Scholar 

  17. 17.

    Ainsworth, E. A. & Gillespie, K. M. Estimation of total phenolic content and other oxidation substrates in plant tissues using Folin-Ciocalteu reagent. Nat Protoc 2, 875–877 (2007).

    CAS  Article  Google Scholar 

  18. 18.

    Skouta, R. et al. Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models. J Am Chem Soc 136, 4551–4556 (2014).

    CAS  Article  Google Scholar 

  19. 19.

    Blois, M. S. Antioxidant Determinations by the Use of a Stable Free Radical. Nature 181, 1199 (1958).

    ADS  CAS  Article  Google Scholar 

  20. 20.

    Yodoi, J. et al. TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells). J Immunol 134, 1623–1630 (1985).

    CAS  PubMed  Google Scholar 

  21. 21.

    Nagy, Z. S. et al. STAT5 regulation of BCL10 parallels constitutive NFkappaB activation in lymphoid tumor cells. Mol Cancer 8, 67 (2009).

    Article  Google Scholar 

  22. 22.

    Nagy, Z. S., Rui, H., Stepkowski, S. M., Karras, J. & Kirken, R. A. A preferential role for STAT5, not constitutively active STAT3, in promoting survival of a human lymphoid tumor. J Immunol 177, 5032–5040 (2006).

    CAS  Article  Google Scholar 

  23. 23.

    Hurwitz, R. et al. Characterization of a leukemic cell line of the pre-B phenotype. Int J Cancer 23, 174–180 (1979).

    CAS  Article  Google Scholar 

  24. 24.

    Schneider, U., Schwenk, H. U. & Bornkamm, G. Characterization of EBV-genome negative “null” and “T” cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma. Int J Cancer 19, 621–626 (1977).

    CAS  Article  Google Scholar 

  25. 25.

    Nunes, L. M. et al. The gender of cell lines matters when screening for novel anti-cancer drugs. AAPS J 16, 872–874 (2014).

    CAS  Article  Google Scholar 

  26. 26.

    Lema, C., Varela-Ramirez, A. & Aguilera, R. J. Differential nuclear staining assay for high-throughput screening to identify cytotoxic compounds. Curr Cell Biochem 1, 1–14 (2011).

    PubMed  PubMed Central  Google Scholar 

  27. 27.

    Cheng, H., Ross, J. A., Frost, J. A. & Kirken, R. A. Phosphorylation of human Jak3 at tyrosines 904 and 939 positively regulates its activity. Mol Cell Biol 28, 2271–2282 (2008).

    CAS  Article  Google Scholar 

  28. 28.

    Varela-Ramirez, A., Costanzo, M., Carrasco, Y. P., Pannell, K. H. & Aguilera, R. J. Cytotoxic effects of two organotin compounds and their mode of inflicting cell death on four mammalian cancer cells. Cell Biol Toxicol 27, 159–168 (2011).

    CAS  Article  Google Scholar 

  29. 29.

    Fruman, D. A. et al. The PI3K Pathway in Human Disease. Cell 170, 605–635 (2017).

    CAS  Article  Google Scholar 

  30. 30.

    Lu, Z. & Xu, S. ERK1/2 MAP kinases in cell survival and apoptosis. IUBMB Life 58, 621–631 (2006).

    CAS  Article  Google Scholar 

  31. 31.

    Cholez, E. et al. Evidence for a protective role of the STAT5 transcription factor against oxidative stress in human leukemic pre-B cells. Leukemia 26, 2390–2397 (2012).

    CAS  Article  Google Scholar 

  32. 32.

    Gallipoli, P. et al. JAK2/STAT5 inhibition by nilotinib with ruxolitinib contributes to the elimination of CML CD34+ cells in vitro and in vivo. Blood 124, 1492–1501 (2014).

    CAS  Article  Google Scholar 

  33. 33.

    Pandey, K. B. & Rizvi, S. I. Plant polyphenols as dietary antioxidants in human health and disease. Oxid Med Cell Longev 2, 270–278 (2009).

    Article  Google Scholar 

  34. 34.

    Liu, R. H. Health benefits of fruit and vegetables are from additive and synergistic combinations of phytochemicals. Am J Clin Nutr 78, 517S–520S (2003).

    CAS  Article  Google Scholar 

  35. 35.

    Eberhardt, M. V., Lee, C. Y. & Liu, R. H. Antioxidant activity of fresh apples. Nature 405, 903–904 (2000).

    ADS  CAS  Article  Google Scholar 

  36. 36.

    Neto, C. C., Amoroso, J. W. & Liberty, A. M. Anticancer activities of cranberry phytochemicals: an update. Mol Nutr Food Res 52(Suppl 1), S18–27 (2008).

    PubMed  Google Scholar 

  37. 37.

    Ajila, C. M. & Prasada Rao, U. J. Protection against hydrogen peroxide induced oxidative damage in rat erythrocytes by Mangifera indica L. peel extract. Food Chem Toxicol 46, 303–309 (2008).

    CAS  Article  Google Scholar 

  38. 38.

    Magalhaes, A. S. et al. Protective effect of quince (Cydonia oblonga Miller) fruit against oxidative hemolysis of human erythrocytes. Food Chem Toxicol 47, 1372–1377 (2009).

    CAS  Article  Google Scholar 

  39. 39.

    Sundaram, S., Anjum, S., Dwivedi, P. & Rai, G. K. Antioxidant activity and protective effect of banana peel against oxidative hemolysis of human erythrocyte at different stages of ripening. Appl Biochem Biotechnol 164, 1192–1206 (2011).

    CAS  Article  Google Scholar 

  40. 40.

    Guizani, N. et al. Papaya epicarp extract protects against hydrogen peroxide-induced oxidative stress in human SH-SY5Y neuronal cells. Exp Biol Med (Maywood) 236, 1205–1210 (2011).

    CAS  Article  Google Scholar 

  41. 41.

    Dammak, I., Boudaya, S., Abdallah, F. B., Hamida, T. & Attia, H. Date seed oil inhibits hydrogen peroxide-induced oxidative stress in normal human epidermal melanocytes. Connect Tissue Res 50, 330–335 (2009).

    Article  Google Scholar 

  42. 42.

    Yang, B., Kotani, A., Arai, K. & Kusu, F. Estimation of the antioxidant activities of flavonoids from their oxidation potentials. Anal Sci 17, 599–604 (2001).

    CAS  Article  Google Scholar 

  43. 43.

    Sayin, V. I. et al. Antioxidants accelerate lung cancer progression in mice. Sci Transl Med 6, 221ra215 (2014).

    Article  Google Scholar 

  44. 44.

    Le Gal, K. et al. Antioxidants can increase melanoma metastasis in mice. Sci Transl Med 7, 308re308 (2015).

  45. 45.

    Santiago-Vazquez, Y. et al. Tumor-selective cytotoxicity of a novel pentadiene analogue on human leukemia/lymphoma cells. Clin Cancer Drugs 3, 138–146 (2016).

    CAS  Article  Google Scholar 

  46. 46.

    Bromann, P. A., Korkaya, H. & Courtneidge, S. A. The interplay between Src family kinases and receptor tyrosine kinases. Oncogene 23, 7957–7968 (2004).

    CAS  Article  Google Scholar 

  47. 47.

    Xu, Y., Harder, K. W., Huntington, N. D., Hibbs, M. L. & Tarlinton, D. M. Lyn tyrosine kinase: accentuating the positive and the negative. Immunity 22, 9–18 (2005).

    PubMed  Google Scholar 

  48. 48.

    Luciano, F., Herrant, M., Jacquel, A., Ricci, J. E. & Auberger, P. The p54 cleaved form of the tyrosine kinase Lyn generated by caspases during BCR-induced cell death in B lymphoma acts as a negative regulator of apoptosis. FASEB J 17, 711–713 (2003).

    CAS  Article  Google Scholar 

  49. 49.

    Wickremasinghe, R. G., Prentice, A. G. & Steele, A. J. Aberrantly activated anti-apoptotic signalling mechanisms in chronic lymphocytic leukaemia cells: clues to the identification of novel therapeutic targets. Br J Haematol 153, 545–556 (2011).

    CAS  Article  Google Scholar 

  50. 50.

    Katagiri, K. et al. Lyn and Fgr protein-tyrosine kinases prevent apoptosis during retinoic acid-induced granulocytic differentiation of HL-60 cells. The Journal of biological chemistry 271, 11557–11562 (1996).

    CAS  Article  Google Scholar 

  51. 51.

    Wheeler, S. E. et al. Lyn kinase mediates cell motility and tumor growth in EGFRvIII-expressing head and neck cancer. Clin Cancer Res 18, 2850–2860 (2012).

    CAS  Article  Google Scholar 

  52. 52.

    Stettner, M. R. et al. Lyn kinase activity is the predominant cellular SRC kinase activity in glioblastoma tumor cells. Cancer Res 65, 5535–5543 (2005).

    CAS  Article  Google Scholar 

  53. 53.

    Ingley, E. Functions of the Lyn tyrosine kinase in health and disease. Cell Commun Signal 10, 21 (2012).

    CAS  Article  Google Scholar 

  54. 54.

    Ruiz-Medina, B. E., Ross, J. A. & Kirken, R. A. Interleukin-2 Receptor beta Thr-450 Phosphorylation Is a Positive Regulator for Receptor Complex Stability and Activation of Signaling Molecules. J Biol Chem 290, 20972–20983 (2015).

    CAS  Article  Google Scholar 

  55. 55.

    Bommhardt, U. et al. Akt decreases lymphocyte apoptosis and improves survival in sepsis. J Immunol 172, 7583–7591 (2004).

    CAS  Article  Google Scholar 

  56. 56.

    Jones, R. G. et al. Protein kinase B regulates T lymphocyte survival, nuclear factor kappaB activation, and Bcl-X(L) levels in vivo. J Exp Med 191, 1721–1734 (2000).

    CAS  Article  Google Scholar 

  57. 57.

    Morishita, N. et al. Activation of Akt is associated with poor prognosis and chemotherapeutic resistance in pediatric B-precursor acute lymphoblastic leukemia. Pediatr Blood Cancer 59, 83–89 (2012).

    Article  Google Scholar 

  58. 58.

    Iqbal, M. S., Tsuyama, N., Obata, M. & Ishikawa, H. A novel signaling pathway associated with Lyn, PI 3-kinase and Akt supports the proliferation of myeloma cells. Biochem Biophys Res Commun 392, 415–420 (2010).

    CAS  Article  Google Scholar 

  59. 59.

    Bunda, S., Qin, K., Kommaraju, K., Heir, P. & Ohh, M. Juvenile myelomonocytic leukaemia-associated mutation in Cbl promotes resistance to apoptosis via the Lyn-PI3K/AKT pathway. Oncogene 34, 789–797 (2015).

    CAS  Article  Google Scholar 

  60. 60.

    Kolch, W. Coordinating ERK/MAPK signalling through scaffolds and inhibitors. Nat Rev Mol Cell Biol 6, 827–837 (2005).

    CAS  Article  Google Scholar 

  61. 61.

    Ripple, M. O., Kalmadi, S. & Eastman, A. Inhibition of either phosphatidylinositol 3-kinase/Akt or the mitogen/extracellular-regulated kinase, MEK/ERK, signaling pathways suppress growth of breast cancer cell lines, but MEK/ERK signaling is critical for cell survival. Breast Cancer Res Treat 93, 177–188 (2005).

    CAS  Article  Google Scholar 

  62. 62.

    Ross, J. A., Nagy, Z. S., Cheng, H., Stepkowski, S. M. & Kirken, R. A. Regulation of T cell homeostasis by JAKs and STATs. Arch Immunol Ther Exp (Warsz) 55, 231–245 (2007).

    CAS  Article  Google Scholar 

Download references


Authors thank Ms. Gladys Almodovar and the staff of the Border Biomedical Research Center (BBRC) Core Facilities at UTEP for services and accommodations provided. The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of BBRC, UTEP, RCMI, NSF-REU, NIGMS, NIMHD or NIH. This work was supported in part by NIGMS SCORE Grants 1SC3GM088069 and 1SC3GM103713 to R.J.A. Also, support grants from the Lizanell and Colbert Coldwell Foundation to ER-E, Edward N. and Margaret G. Marsh Foundation, The Shiloff Family Foundation and 5G12MD007592 from RCMI-NIMHD-NIH to R.A.K. Moreover, thanks to grants from the Lung Cancer Research Foundation (LCRF) and the Green Fund grants to RS. DL and ER-E were supported by the Research Experience for Undergraduates program funded by NSF-REU grant DBI-0851881 and by the RISE Scholars Program at UTEP through NIGMS Grant R25GM069621-12, respectively.

Author information




B.R.-M., E.R.-E. and A.V.-R. designed the study. B.R.-M., D.L., M.H., R.S., A.V.-R. and E.R.-E. performed the experiments. B.R.-M., D.L., M.H., J.A.R., R.S., R.J.A., R.A.K., A.V.-R. and E.R.-E. analyzed the data and created the figures. B.R.-M., E.R.-E. and A.V.-R. wrote the manuscript. All authors read and approved the manuscript.

Corresponding authors

Correspondence to Armando Varela-Ramirez or Elisa Robles-Escajeda.

Ethics declarations

Competing Interests

The authors declare no competing interests.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ruiz-Medina, B.E., Lerma, D., Hwang, M. et al. Green barley mitigates cytotoxicity in human lymphocytes undergoing aggressive oxidative stress, via activation of both the Lyn/PI3K/Akt and MAPK/ERK pathways. Sci Rep 9, 6005 (2019).

Download citation

Further reading


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing